A pharmacokinetic study of the oral formulation of PL-8177
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2019
At a glance
- Drugs PL 8177 (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- 12 Feb 2019 according to a Palatin Technologies media release, this trial was started during the quarter ended December 31, 2018, with data expected in the first quarter of calendar year 2019.
- 12 Feb 2019 Status changed from planning to recruiting, according to a Palatin Technologies media release.
- 08 Nov 2018 According to a Palatin Technologies media release, data from the study is currently expected by the end of 2018.